Trial Profile
Bevacizumab alone or with chemotherapy in patients with recurrent ovarian cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 27 Oct 2015 New trial record